MTIP Announces Majority Investment
in Verifarma

MTIP is pleased to announce a majority investment in Verifarma, a leading provider of integrated serialization, traceability, and regulatory compliance solutions for the pharmaceutical industry, headquartered in Spain.

‍

Founded in 2007, Verifarma has grown into a trusted, high-growth, and profitable SaaS provider serving 2000 companies across 26 countries. The company holds a leading position in Latin America and a growing presence in Europe, supporting pharmaceutical manufacturers, wholesalers, and distributors in meeting global traceability requirements. Its end-to-end platform spans the full supply chain - from production to regulatory reporting - and helps ensure the safety and authenticity of medicines worldwide. In addition, Verifarma’s Quality Management System (eQMS) represents a fast-growing and increasingly strategic component of the product offering, complemented by its broader portfolio of regulatory and compliance-focused software solutions.

‍

MTIP is partnering with Verifarma's four Co-Founders - CEO Santiago Spector Mentasti, CFO Ignacio Los Daneri, COO T&T Rodrigo López Martínez, and Chief AI Officer Sebastián Migliorisi - who will continue to lead the business and remain significant shareholders. The investment will accelerate Verifarma's next phase of growth, with a focus on deepening its core track-and-trace technology platform, further scaling its quality management capabilities, enhancing its AI-driven capabilities across the platform, expanding its European go-to-market presence, and investing in its diverse and growing customer base across Latin America and beyond.

‍

"We founded Verifarma nearly 20 years ago with a clear mission: To make pharmaceutical supply chains safer and more transparent," said Santiago Spector Mentasti, CEO and Co-Founder of Verifarma." MTIP shares our vision and our ambition. This investment gives us the resources and expertise to accelerate what we have built - to deepen our product, strengthen our team, and bring our platform to more customers across Europe and globally. We are fully committed to this next chapter of growth."

‍

"We are excited about joining forces with Verifarma and its exceptional founding team," said Marton Kenessey, Investment Director at MTIP." Santiago, Ignacio, Rodrigo, and Sebastián have created something truly differentiated - a profitable, fast-growing software business with a compelling mission at its heart and a strong commitment to customer care and long-term relationships. With our deep experience in scaling healthcare technology companies, we look forward to supporting Verifarma’s continued international expansion and further developing its platform."

‍

About Verifarma

Verifarma is a leading provider of integrated software solutions for the pharmaceutical and life sciences industry, spanning serialization and traceability, quality management (eQMS), regulatory affairs, and pharmacovigilance. Its platform enables end-to-end visibility and compliance across the supply chain, helping companies meet global regulatory requirements and ensure the safety and authenticity of medicines worldwide.

‍

For more information, please visit: www.verifarma.com

About MTIP

MTIP is a Swiss-based specialist growth and buyout investor focused on European healthcare technology. We invest in AI-enabled and software-driven healthcare companies through majority and minority structures, partnering closely with founders and management teams to scale market-leading businesses. With deep sector expertise and an active ownership approach, we drive sustainable growth and long-term value creation for our portfolio companies and investors.

‍

For more information, please visit www.mtip.ch.  

‍

Media Contact:
Anja-Vanessa Peter

Investor Relations & Communication Manager

anja.peter@mtip.ch

‍